Literature DB >> 25598993

Coronary spasm during cardiac electrophysiological study following isoproterenol infusion.

Narendra Kumar, Ismail Aksoy, Kevin Phan, Jindra Vainer, Carl Timmermans.   

Abstract

Sudden cardiac death (SCD) remains the leading cause of death in industrialized world. The majority of SCD is caused by ventricular fibrillation associated with structural and/or ischemic heart disease. Ventricular fibrillation represents the final common pathway for SCD and, thus, is an attractive target for ablation. According to class I recommendation level of evidence A, an implantable cardioverter defibrillator (ICD) should be implanted for such patients [1]. Other than programmed electrical extrastimulus technique, isoproterenol infusion is commonly used in invasive cardiac electrophysiology labs for arrhythmia induction. We hereby report a rare case of transient coronary spasm during isoproterenol infusion for ventricular tachycardia induction testing.

Entities:  

Keywords:  complication; coronary spasm; electrophysiology study; isoproterenol; sudden cardiac death

Year:  2014        PMID: 25598993      PMCID: PMC4274359          DOI: 10.1556/IMAS.6.2014.4.7

Source DB:  PubMed          Journal:  Interv Med Appl Sci        ISSN: 2061-1617


  11 in total

1.  Electrophysiologic effects of isoproterenol on cardiac conduction system in man.

Authors:  G Vargas; M Akhtar; A N Damato
Journal:  Am Heart J       Date:  1975-07       Impact factor: 4.749

2.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2008-05-15       Impact factor: 29.690

3.  Alterations of autonomic nervous activity preceding nocturnal variant angina: sympathetic augmentation with parasympathetic impairment.

Authors:  K Miwa; A Igawa; Y Miyagi; K Nakagawa; H Inoue
Journal:  Am Heart J       Date:  1998-05       Impact factor: 4.749

4.  Autonomic changes associated with spontaneous coronary spasm in patients with variant angina.

Authors:  G A Lanza; P Pedrotti; V Pasceri; M Lucente; F Crea; A Maseri
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

5.  Alterations of autonomic nervous activity in recurrence of variant angina.

Authors:  M Takusagawa; S Komori; K Umetani; T Ishihara; T Sawanobori; I Kohno; S Sano; D Yin; H Ijiri; K Tamura
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

6.  Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm.

Authors:  H Yasue; Y Horio; N Nakamura; H Fujii; N Imoto; R Sonoda; K Kugiyama; K Obata; Y Morikami; T Kimura
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

7.  Usefulness of isoproterenol facilitation of ventricular tachycardia induction during extrastimulus testing in predicting effective chronic therapy with beta-adrenergic blockade.

Authors:  B Olshansky; J B Martins
Journal:  Am J Cardiol       Date:  1987-03-01       Impact factor: 2.778

8.  Provocation of coronary vasospastic angina using an isoproterenol head-up tilt test.

Authors:  Ming-Jui Hung; Chao-Hung Wang; Wen-Jin Cherng
Journal:  Angiology       Date:  2004 May-Jun       Impact factor: 3.619

9.  Use of isoproterenol during programmed ventricular stimulation in patients with coronary artery disease and nonsustained ventricular tachycardia.

Authors:  M Niebauer; E Daoud; R Goyal; K K Chan; M Harvey; F Bogun; M Castellani; K C Man; S A Strickberger; F Morady
Journal:  Am Heart J       Date:  1996-03       Impact factor: 4.749

10.  Sudden cardiac death and polymorphous ventricular tachycardia in patients with normal QT intervals and normal systolic cardiac function.

Authors:  S J Eisenberg; M M Scheinman; N K Dullet; W E Finkbeiner; J C Griffin; M Eldar; M R Franz; R Gonzalez; A H Kadish; M D Lesh
Journal:  Am J Cardiol       Date:  1995-04-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.